ABOS
Acumen Pharmaceuticals, Inc. Common Stock
stockNASDAQ
Market OpenNov 11, 2026 1:27:12 PM EST
0.23USD-0.565%(-0.00)874,985
Pre-marketNov 11, 2026 9:19:30 AM EST
0.2306USD+0.261%(+0.0006)
ABOS Financials
In Q3 FY 2026 (ended ), Acumen Pharmaceuticals, Inc. Common Stock (ABOS) reported net income of −$25.37M, operating cash flow of −$26.65M, and assets of $85.57M (filed ).
Loading financial flows…